[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

COVID 19

FDA recommends inclusion of BA.4, BA.5 subvariants in COVID boosters

06/30/2022

Less than a minute

2022.06.30 17:29

FDA recommends inclusion of BA.4

Budrigannews – The U.S. Food and Drug Administration on Thursday recommended the inclusion of Omicron BA.4 and BA.5 subvariants as a part of COVID-19 booster doses.

The regulators move comes after advisers to the health regulator on Tuesday recommended a change in the design of COVID-19 booster shots this fall in order to combat more recently circulating variants of the coronavirus.

06/30/2022

Less than a minute